
Berthold Schenkel, PhD
Advertisement
Berthold Schenkel, PhD, is head of technology group 1, CHBS, at Novartis Pharma AG
Articles by Berthold Schenkel, PhD

Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
Zai Lab’s Long-Acting Atopic Dermatitis Bispecific Points to Every-12-Week Dosin
2
ImvivaBio’s Dual-Target Allogeneic CAR-T Sustains Lupus Remission Through 12 Months
3
FDA Reportedly Pauses National Priority Voucher Pilot and Pauses CRL Publication
4
Ionis Reports 2-Year Donidalorsen (Dawnzera) Data in HAE Prophylaxis
5


